Biopharm Reports
Biopharm Reports provides market research services to the pharmaceutical and biomedical industries and publishes global reviews on markets, developments and pipeline. It is an independent commercial research company that carries out assessments of products, technologies and services. Biopharm Reports uses primary research methods to ensure that their findings are accurate, current and reliable.
Biopharm Reports supplies with information to help companies compete more effectively in the marketplace, differentiating themselves from their competitors. The company evaluates both markets and people important to customers’ business development plans.
Mass Spectrometry 2013 presents the findings of a global market study of mass spectrometry, involving the participation of 567 buyers and end-users in this field. With a focus on market development, sales growth and commercial opportunities, the study profiled ...
Feb, 2013 262 pages... are an inevitable consequence of longer treatment times (durations of infection), due to antibiotic resistance. Also, the more time that is required to eradicate a pathogen ... two decades, coupled with an evident fall in the numbers of new antibiotics being approved during this time, has long raised concerns ...
Feb, 2013 118 pages... . Biopharm Reports has published a new report on the use of software and databases in the life science field. This is the outcome of six global studies ... flow cytometry and disease biomarker fields. These estimates are based on published market sizes of these fields, and the present study findings described in ...
Feb, 2013 102 pages... Biopharm Reports has carried out six studies in the life science field, which examined the use of consumables in the conduct of PCR, DNA sequencing, DNA ... flow cytometry and disease biomarker fields. These estimates are based on published market sizes of these fields, and the present study findings described in ...
Feb, 2013 105 pagesFlow Cytometry 2013 presents the findings of a global market study of flow cytometry, involving the participation of 277 buyers and end-users ... outcome of an extensive global study involving 277 experienced flow cytometry users. It's findings provide a “focus on sales growth” to developers and vendors in the ...
Feb, 2013 167 pages... biomarkers to enable those patients most likely to benefit from VEGF inhibition, to be identified. This report provides a review of findings to date on biomarkers associated with the use bevacizumab (Avastin®); both therapy-indicating and prognostic. The identification of therapy-indicating and prognostic ...
Feb, 2013 103 pages... the participation of 733 buyers and end-users in this field. With a focus on market development, sales growth and commercial opportunities, the study profiled ... the global markets for microarray, flow cytometry and mass spectrometry put together. PCR 2013, a global study involving the participation of 733 PCR ...
Feb, 2013 162 pagesDNA Microarray 2013 presents the findings of a global market study of DNA Microarray, involving the participation of 201 buyers and end-users in ... global study involving more than 200 experienced DNA microarray buyers and end-users. It's findings provide a “focus on sales growth” to developers and vendors in ...
Feb, 2013 149 pages
